This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woolard, M. D.
Right arrow Articles by Simecka, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woolard, M. D.
Right arrow Articles by Simecka, J. W.

 Previous Article  |  Next Article 

Infection and Immunity, October 2005, p. 6742-6751, Vol. 73, No. 10
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.10.6742-6751.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

NK Cells in Gamma-Interferon-Deficient Mice Suppress Lung Innate Immunity against Mycoplasma spp.

Matthew D. Woolard,1,{dagger} Dorothy Hudig,2 Leslie Tabor,1 James A. Ivey,1 and Jerry W. Simecka1*

Department of Molecular Biology and Immunology, University of North Texas Health Science Center in Fort Worth, Fort Worth, Texas 76107,1 Cell and Molecular Biology Program, School of Medicine and College of Agriculture, University of Nevada, Reno, Nevada 895572

Received 22 April 2005/ Returned for modification 15 June 2005/ Accepted 27 June 2005

The purpose of this study was to examine the 100-fold difference in mycoplasma levels in lungs of gamma interferon knockout (IFN-{gamma}–/–) mice compared to those seen with wild-type BALB/c mice at 3 days postinfection. NK cells secreted IFN-{gamma}; however, their cytotoxic granule extracts failed to kill mycoplasma. We found a conundrum: the clearance of organisms was as effective in NK-depleted IFN-{gamma}–/– animals as in wild-type mice (with both IFN-{gamma} and NK cells). NK+ IFN-{gamma}–/– animals had high mycoplasma burdens, but, after NK-like cell depletion, mycoplasma numbers were controlled. Essentially, IFN-{gamma} was important in animals with NK-like cells and unimportant in animals without NK cells, suggesting that IFN-{gamma} counters deleterious effects of NK-like cells. Impairment of innate immunity in IFN-{gamma}–/– mice was not due to NK-like cell killing of macrophages. The increased levels of inflammatory cytokines and neutrophils in lung fluids of NK+ IFN-{gamma}–/– mice were reduced after NK cell depletion. In summary, in the murine model that resembles chronic human disease, innate immunity to mycoplasma requires IFN-{gamma} when there are NK-like cells and the positive effects of IFN-{gamma} counteract negative effects of NK-like cells. When imbalanced, NK-like cells promote disease. Thus, it was not the lack of IFN-{gamma} but the presence of a previously unrecognized NK-like cell-suppressive activity that contributed to the higher mycoplasma numbers. It appears that pulmonary NK cells may contribute to the immunosuppressive environment of the lung, but when needed, these dampening effects can be counterbalanced by IFN-{gamma}. Furthermore, there may be instances where perturbation of this regulatory balance contributes to the susceptibility to and severity of disease.

* Corresponding author. Mailing address: Department of Molecular Biology and Immunology, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107. Phone: (817) 735-2116. Fax: (817) 735-2651. E-mail: jsimecka{at}hsc.unt.edu.

Editor: J. N. Weiser

{dagger} Present address: Department of Microbiology and Immunology, University of North Carolina, CB# 7290 Jones, Chapel Hill NC 27599-7290.

Infection and Immunity, October 2005, p. 6742-6751, Vol. 73, No. 10
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.10.6742-6751.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Lu, C.-C., Lai, H.-C., Hsieh, S.-C., Chen, J.-K. (2008). Resveratrol ameliorates Serratia marcescens-induced acute pneumonia in rats. J. Leukoc. Biol. 83: 1028-1037 [Abstract] [Full Text]  
  • Salvatore, C. M., Fonseca-Aten, M., Katz-Gaynor, K., Gomez, A. M., Hardy, R. D. (2008). Intranasal Interleukin-12 Therapy Inhibits Mycoplasma pneumoniae Clearance and Sustains Airway Obstruction in Murine Pneumonia. Infect. Immun. 76: 732-738 [Abstract] [Full Text]  
  • Salvatore, C. M., Fonseca-Aten, M., Katz-Gaynor, K., Gomez, A. M., Mejias, A., Somers, C., Chavez-Bueno, S., McCracken, G. H., Hardy, R. D. (2007). Respiratory Tract Infection with Mycoplasma pneumoniae in Interleukin-12 Knockout Mice Results in Improved Bacterial Clearance and Reduced Pulmonary Inflammation. Infect. Immun. 75: 236-242 [Abstract] [Full Text]  
  • Sun, X., Jones, H. P., Hodge, L. M., Simecka, J. W. (2006). Cytokine and Chemokine Transcription Profile during Mycoplasma pulmonis Infection in Susceptible and Resistant Strains of Mice: Macrophage Inflammatory Protein 1{beta} (CCL4) and Monocyte Chemoattractant Protein 2 (CCL8) and Accumulation of CCR5+ Th Cells.. Infect. Immun. 74: 5943-5954 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»